SCHEMBL9501093

SCHEMBL9501093

O=C(O)c1cn(C2CC2)c2cc(F)c(F)c(NCc3ccccc3)c2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 16/20 0.54
KDM4E B2RXH2 1/20 0.43
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
IKBKB O14920 1/20 0.42
AURKA O14965 1/20 0.42
CHUK O15111 1/20 0.42
MAPK13 O15264 1/20 0.42
DAPK3 O43293 1/20 0.42
PRKCG P05129 1/20 0.42
PIM1 P11309 1/20 0.42
CDK2 P24941 1/20 0.42
MARK3 P27448 1/20 0.42
AKT1 P31749 1/20 0.42
AKT2 P31751 1/20 0.42
MAPKAPK2 P49137 1/20 0.42
GSK3A P49840 1/20 0.42
NEK2 P51955 1/20 0.42
PLK1 P53350 1/20 0.42
MAPK12 P53778 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9502058 0.89 ADRB2 (0.48) GSK3BKDM4EIKBKBAURKACHUK
SCHEMBL10550876 0.84 GSK3B (0.63) GSK3BTOP2ATOP2B
SCHEMBL1345409 0.83 ADRB2 (0.43) GSK3BKDM4E
SCHEMBL9502093 0.81 KCNH2 (0.70) GSK3BKDM4EKCNH2HRH3TOP2A
SCHEMBL9503714 0.80 KCNH2 (0.51) GSK3BKDM4EKCNH2HRH3
SCHEMBL9501339 0.79 KCNH2 (0.55) GSK3BKDM4EKCNH2HRH3TOP2A
SCHEMBL7495837 0.77 KCNH2 (0.51) GSK3BKDM4EKCNH2HRH3TOP2A
SCHEMBL5508837 0.77 KCNH2 (0.64) GSK3BKDM4EKCNH2HRH3TOP2A
SCHEMBL30181127 0.77 KCNH2 (0.64) GSK3BKDM4EKCNH2HRH3TOP2A
SCHEMBL10546585 0.77 GSK3B (0.55) GSK3BKDM4EKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0312085-B1 NOVEL QUINOLINE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND ANTIBACTERIAL AGENT CONTAINING THEM Dainippon Pharmaceutical Co., Ltd. (JP) 1993-05-12 EP disclosed
US-5164392-A Active against streptococci and staphylococci DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1992-11-17 US disclosed
US-5013841-A Oxo quinoline derivatives DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1991-05-07 US disclosed
EP-0312085-A2 Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them Dainippon Pharmaceutical Co., Ltd. (JP) 1989-04-19 EP disclosed